On February 1st 2019, the FDA announced its approval of a new alternative to Allergan’s Botox, known as Jeuveau. Marketed by Evolus, a medical aesthetics company, Jeuveau is the first product expected to challenge Botox in the improvement of prominent facial moderate to severe frown lines, commonly referred to as expression lines, in both men …Read More